Prion proteins with insertion mutations have altered N-terminal conformation and increased ligand binding activity and are more susceptible to oxidative attack

被引:37
作者
Yin, SM
Yu, SL
Li, CY
Wong, P
Chang, BG
Xiao, F
Kang, SC
Yan, HM
Xiao, GF
Grassi, J
Tien, P
Sy, MS
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44120 USA
[2] Chinese Acad Sci, Inst Microbiol, Beijing 100080, Peoples R China
[3] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Hubei, Peoples R China
[4] CEA Saclay, CEA, Serv Pharmacol & Immunol, F-91191 Gif Sur Yvette, France
关键词
D O I
10.1074/jbc.M511819200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We compared the biochemical properties of a wild type recombinant normal human cellular prion protein, rPrP(c), with a recombinant mutant human prion protein that has three additional octapeptide repeats, rPrP(8OR). Monoclonal antibodies that are specific for the N terminus of rPrP(c) react much better with rPrP(8OR) than rPrP(c), suggesting that the N terminus of rPrP(8OR) is more exposed and hence more available for antibody binding. The N terminus of PrPc contains a glycosaminoglycan binding motif. Accordingly, rPrP(8OR) also binds more glycosaminoglycan than rPrP(c). In addition, the divalent cation copper modulates the conformations of rPrP(c) and rPrP(8OR) differently. When compared with rPrP(c), rPrP(8OR) is also more susceptible to oxidative damage. Furthermore, the abnormalities associated with rPrP(8OR) are recapitulated, but even more profoundly, in another insertion mutant, which has five extra octapeptide repeats, rPrP(10OR). Therefore, insertion mutants appear to share common features, and the degree of abnormality is proportional to the number of insertions. Any of these anomalies may contribute to the pathogenesis of inherited human prion disease.
引用
收藏
页码:10698 / 10705
页数:8
相关论文
共 47 条
[1]   Mitochondrial metabolism of reactive oxygen species [J].
Andreyev, AI ;
Kushnareva, YE ;
Starkov, AA .
BIOCHEMISTRY-MOSCOW, 2005, 70 (02) :200-214
[2]   Protein oxidation in aging, disease, and oxidative stress [J].
Berlett, BS ;
Stadtman, ER .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) :20313-20316
[3]  
Bonomo RP, 2000, CHEM-EUR J, V6, P4195, DOI 10.1002/1521-3765(20001117)6:22<4195::AID-CHEM4195>3.0.CO
[4]  
2-2
[5]   Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi [J].
Brown, LR ;
Harris, DA .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (02) :353-363
[6]   Allelic origin of the abnormal prion protein isoform in familial prion diseases [J].
Chen, SG ;
Parchi, P ;
Brown, P ;
Capellari, S ;
Zou, WQ ;
Cochran, EJ ;
VnencakJones, CL ;
Julien, J ;
Vital, C ;
Mikol, J ;
Lugaresi, E ;
AutilioGambetti, L ;
Gambetti, P .
NATURE MEDICINE, 1997, 3 (09) :1009-1015
[7]  
Chevion M, 2000, FREE RADICAL RES, V33, pS99
[8]   Molecular distinction between pathogenic and infectious properties of the prion protein [J].
Chiesa, R ;
Piccardo, P ;
Quaglio, E ;
Drisaldi, B ;
Si-Hoe, SL ;
Takao, M ;
Ghetti, B ;
Harris, DA .
JOURNAL OF VIROLOGY, 2003, 77 (13) :7611-7622
[9]   Neurological illness in transgenic mice expressing a prion protein with an insertional mutation [J].
Chiesa, R ;
Piccardo, P ;
Ghetti, B ;
Harris, DA .
NEURON, 1998, 21 (06) :1339-1351
[10]   Octapeptide repeat insertions in the prion protein gene and early onset dementia [J].
Croes, EA ;
Theuns, J ;
Houwing-Duistermaat, JJ ;
Dermaut, B ;
Sleegers, K ;
Roks, G ;
Van den Broeck, M ;
van Harten, B ;
van Swieten, JC ;
Cruts, M ;
Van Broeckhoven, C ;
van Duijn, CM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08) :1166-1170